| Literature DB >> 35510362 |
Abstract
In this issue of Blood Cancer Discovery, Wintersinger and colleagues present a new algorithm for quickly and accurately inferring clonal phylogenies from heterogeneous tumors sampled at many timepoints and/or many sites. When coupled with serial sequencing of tumors, this advance promises to increase our understanding of the clonal dynamics that shape tumor evolution and response to therapy. See related article by Wintersinger et al., p. 208 (9). ©2022 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35510362 PMCID: PMC9245365 DOI: 10.1158/2643-3230.BCD-22-0036
Source DB: PubMed Journal: Blood Cancer Discov ISSN: 2643-3230